Conjugates of tumor necrosis factor inhibitors to functionalized polymers

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9220789
SERIAL NO

13916251

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This document relates to conjugates of TNF inhibitors or derivatives thereof and functionalized (e.g., mono- or bi-functional) polymers (e.g., polyethylene glycol and related polymers) as well as methods and materials for making and using such conjugates.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
QUIAPEG PHARMACEUTICALS ABVIRDINGS ALLÉ 32 B UPPSALA 754 50

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kwiatkowski, Marek Uppsala, SE 43 1372

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 29, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00